MARCIA GOLDSTEIN: Open Payments
NPI 1538261300 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 37 payments from 12 companies in 2025. Trend: 2023 $1,373 · 2024 $1,835 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $478 |
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| AKEBIA THERAPEUTICS INC | 4 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $178 |
| Ardelyx, Inc. | 4 | $120 |
| Gilead Sciences, Inc. | 1 | $117 |
| Novo Nordisk Inc | 1 | $105 |
| Calliditas Therapeutics US Inc. | 2 | $48 |
| Vifor Pharma, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: BREZTRI, Vafseo, AIRSUPRA, IBSRELA, FASENRA, Descovy, Vanrafia, JARDIANCE.
Industry payments across PA — which companies pay providers there.
